首页> 外文期刊>Journal of drug targeting >The promising potentials of capped gold nanoparticles for drug delivery systems
【24h】

The promising potentials of capped gold nanoparticles for drug delivery systems

机译:用于药物递送系统的封端金纳米粒子的有希望的潜力

获取原文
获取原文并翻译 | 示例
           

摘要

Fabrication and characterisation of gold nanoparticles (GNPs) through reducing agents and different capped agents are one of their most attractive applications in biomedicine. GNPs are coated using various agents such as carbohydrate, amino acids, peptides and proteins. These capped gold nanoparticles (C-GNPs) are applied for wide different applications including drug delivery in the recent decade and potential treatment and diagnosis in drug delivery systems (DDS). Recent studies have shown that these novel compounds and conjugated-nanoparticles drugs play a key role for the promising cure of high-risk refractory diseases. In addition, it seems that these compounds have a capability for potential treatment of certain cancers. In this review, a well-defined description of C-GNPs and the application of these nanoparticles are discussed. Our study revealed that C-GNPs with anticancer drugs or new compounds could be potentially applied for biomedical usage especially in cancer therapy. ? 2017 Informa UK Limited, trading as Taylor & Francis Group.
机译:通过还原剂和不同封端剂的金纳米颗粒(GNP)的制造和表征是其生物医学中最具吸引力的应用之一。使用各种试剂如碳水化合物,氨基酸,肽和蛋白质涂覆GNP。这些封端的金纳米颗粒(C-GNP)适用于宽不同的应用,包括近年来的药物递送以及药物递送系统(DDS)的潜在治疗和诊断。最近的研究表明,这些新型化合物和共轭纳米粒子药物对高危难治性疾病的有希望的治愈作出关键作用。此外,似乎这些化合物具有潜在治疗某些癌症的能力。在该评价中,讨论了C-GNP的明确描述和这些纳米颗粒的应用。我们的研究表明,具有抗癌药物或新化合物的C-GNP可能适用于癌症治疗的生物医学用途。还2017年Informa UK Limited,贸易为泰勒&弗朗西斯集团。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号